Tharimmune, Inc. — Director's Dealing 2025

Jan 14, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tharimmune, Inc. (THAR)
CIK: 0001861657
Period of Report: 2025-01-13

Reporting Person: MILBY RANDY (Director, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-13	Options (right to buy)	$1.93	A	80958	Acquired	2035-01-13	Common Stock (80958)	Direct

Footnotes

F1: On January 13, 2025, the Reporting Person was granted options ("Options") to purchase up to 80,958 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vested in full upon grant.